| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |